Akt–the Mammalian Target of Rapamycin (mTOR) Pathway Inhibition Increases Cervical Cancer Cell Chemosensitivity to Active Form of Irinotecan (SN-38). IJIHS. 2013;1(1):13-21. Accessed July 18, 2026. https://journal.fk.unpad.ac.id/index.php/ijihs/article/view/103